The Ciclopoli nail lacquer from Almirall S.A. - quiet, targeted relief for stubborn nail fungus

Reviewed: ad hoc news Classics & Longseller desk. Edited and checked on 2026-06-28, 08:36. Details in the imprint.

The Ciclopoli nail lacquer sits like a thin, glossy film on the toenail, cool for a moment and then almost invisible as it dries. Patients brush it on at night and wake up with a tidy, sealed nail that feels tougher under the fingertip.

What Ciclopoli is made for

Ciclopoli is a medicated nail lacquer for the treatment of nail fungus, using the active ingredient ciclopirox in a water-soluble polymer solution. It is marketed in Germany by Almirall Hermal as small 6.6 ml bottles aimed at long treatment cycles for onychomycosis.

Dermatologists often prescribe Ciclopoli when the infection is limited to the upper part of the nail or when systemic therapy would be disproportionate. The product is positioned as a long-haul therapy that patients can manage themselves at home with regular nightly application and weekly washing.

How the lacquer works in practice

The lacquer is designed to form a breathable film that releases ciclopirox into the nail plate, helping to penetrate the keratin and reach the fungal colonies over time. Because the solution is water-soluble, patients usually rinse and gently file or clean the nail once a week, then reapply the product.

Dr. Martin Scholz, a Hamburg-based dermatologist who regularly treats nail fungus, describes the routine as a quiet ritual: apply the thin coat in the evening, let it dry, forget about it, and return after months to see a cleaner nail grow from the base. For many of his patients, the tactile change from brittle to more robust nail surface is a small but convincing sign that therapy is on track.

Daily handling at the bathroom sink

In a typical evening routine, the patient sits at the edge of the bathtub or bed, feet dry and clean, and uses the small brush built into the cap to coat the entire nail surface. The smell is faintly medicinal but not raw, and the lacquer spreads in a smooth line without dripping.

After a few minutes the surface turns from wet shine to a cleaner matte gloss, so socks do not stick and the coating feels less like nail polish and more like a thin protective shell. For many users, this tactile shell becomes part of the habit, a reminder that treatment is ongoing even when the discoloured nail still looks unchanged in the early weeks.

Where Ciclopoli plays in Almirall's portfolio

Ciclopoli sits alongside other dermatology brands in Almirall's European portfolio, which stretches from psoriasis and atopic dermatitis treatments to acne and rosacea products. Nail fungus therapy is a quieter niche, but chronic, and repeat prescriptions can run over several months for one patient.

For Almirall, the product keeps the company present in everyday pharmacy shelves, not just in specialist hospital formularies. Pharmacists often reach for Ciclopoli boxes when a doctor has written a script, and the compact packaging makes it simple to toss into a handbag or bathroom cabinet without clutter.

Limits of a topical-only strategy

Like other topical nail fungus therapies, Ciclopoli works best when the fungal involvement is still moderate and growth from the nail matrix is not fully compromised. In more advanced cases, doctors may combine systemic antifungals with the lacquer, or choose oral therapy alone if the patient can tolerate it.

Patients can find the months-long horizon sobering, because the damaged nail grows slowly and visible improvement often lags behind the effort. Physicians like Scholz therefore stress that the therapy is not about dramatic overnight change but about consistent use and regular trimming to slowly replace diseased tissue.

Company context and share listing

Almirall S.A. is a Spanish pharmaceutical group focused strongly on dermatology, with headquarters in Barcelona and a listing on the Spanish stock exchange in Madrid. In dermatology it competes with larger multinationals, but maintains a self-assured focus on skin and nail diseases in Europe.

Almirall shares (ISIN ES0157097017) trade on the Bolsa de Madrid in euros, and investors watch how established therapies like Ciclopoli and newer launches contribute to revenue over time without assigning short-term price signals to single products.

This article was AI-assisted and editorially reviewed. Product information without guarantee; prices and availability may change at short notice. No investment advice, no buy or sell recommendation. Stock-market transactions involve risks up to total loss.